» Articles » PMID: 27393567

Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2016 Jul 10
PMID 27393567
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The presence of extramural tumor deposits without lymph node structure (EX) is an important prognostic factor for patients with colorectal cancer. However, the clinical significance of EX in the lateral pelvic lymph node area (LP-EX) remains unclear. This study aimed to determine the prognostic implications of LP-EX for patients with low rectal cancer.

Methods: This retrospective study involved 172 consecutive patients with stage 2 or 3 low rectal cancer who underwent curative surgery including lateral pelvic lymph node (LPLN) dissection. The patients were classified into the following three groups according to the metastatic status of the LPLN area: patients without metastasis (no-LP-M group), patients with lymph node metastasis (LP-LNM group), and patients with EX (LP-EX group). Potential prognostic factors of overall survival (OS) and relapse-free survival (RFS) were identified in uni- and multivariate analyses.

Results: Classification assigned 131 patients (76 %) to the no-LP-M group, 27 patients (16 %) to the LP-LNM group, and 14 patients (8 %) to the LP-EX group. The 5-year OS rate was 80.3 % in the no-LP-M group, 61.1 % in the LP-LNM group, and 34.9 % in the LP-EX group (P < 0.001). The corresponding 5-year RFS rates were 62.2, 33.8, and 14.3 %, respectively (P < 0.001). A multivariate Cox proportional hazards regression analysis showed that the presence of LP-EX was an independent prognostic factor for OS (P = 0.006) and RFS (P = 0.001).

Conclusions: The LP-EX classification is a useful pathologic parameter that can be used to stratify patients with metastasis in the LPLN area.

Citing Articles

The diagnosis and oncological outcomes of obturator and internal iliac lymph node metastasis in middle-low rectal cancer: results of a multicenter Lateral Node Collaborative Group study in China.

Huang F, Wei R, Zhou S, Mei S, Xiao T, Xing W Discov Oncol. 2024; 15(1):618.

PMID: 39497010 PMC: 11535149. DOI: 10.1007/s12672-024-01500-4.


Radiomics for predicting survival in patients with locally advanced rectal cancer: a systematic review and meta-analysis.

Feng Y, Gong J, Hu T, Liu Z, Sun Y, Tong T Quant Imaging Med Surg. 2023; 13(12):8395-8412.

PMID: 38106286 PMC: 10722083. DOI: 10.21037/qims-23-692.


Multiregional-based magnetic resonance imaging radiomics model for predicting tumor deposits in resectable rectal cancer.

Feng F, Liu Y, Bao J, Hong R, Hu S, Hu C Abdom Radiol (NY). 2023; 48(11):3310-3321.

PMID: 37578553 DOI: 10.1007/s00261-023-04013-w.


Progress in the diagnosis of lymph node metastasis in rectal cancer: a review.

Peng W, Qiao H, Mo L, Guo Y Front Oncol. 2023; 13:1167289.

PMID: 37519802 PMC: 10374255. DOI: 10.3389/fonc.2023.1167289.


Clinical significance of metastatic tumor deposit foci in rectal cancer in the lateral pelvic lymph node area.

Yamai D, Shimada Y, Nakano M, Ozeki H, Matsumoto A, Abe K Int J Clin Oncol. 2023; 28(10):1388-1397.

PMID: 37481501 DOI: 10.1007/s10147-023-02391-1.


References
1.
Fujita S, Yamamoto S, Akasu T, Moriya Y . Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis. Hepatogastroenterology. 2012; 59(120):2494-7. DOI: 10.5754/hge12153. View

2.
Kapiteijn E, Marijnen C, Nagtegaal I, Putter H, Steup W, Wiggers T . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345(9):638-46. DOI: 10.1056/NEJMoa010580. View

3.
Paty P, Enker W, Cohen A, Lauwers G . Treatment of rectal cancer by low anterior resection with coloanal anastomosis. Ann Surg. 1994; 219(4):365-73. PMC: 1243153. DOI: 10.1097/00000658-199404000-00007. View

4.
Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls R . Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009; 10(11):1053-62. DOI: 10.1016/S1470-2045(09)70224-4. View

5.
Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S . Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006; 49(11):1663-72. DOI: 10.1007/s10350-006-0714-z. View